1. Home
  2. ZCMD vs ACON Comparison

ZCMD vs ACON Comparison

Compare ZCMD & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

N/A

Current Price

$0.11

Market Cap

7.9M

Sector

Real Estate

ML Signal

N/A

Logo Aclarion Inc.

ACON

Aclarion Inc.

N/A

Current Price

$3.29

Market Cap

8.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ZCMD
ACON
Founded
2012
2008
Country
China
United States
Employees
N/A
11
Industry
Other Consumer Services
Retail: Computer Software & Peripheral Equipment
Sector
Real Estate
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
8.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ZCMD
ACON
Price
$0.11
$3.29
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
7.1M
57.8K
Earning Date
04-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$87.22
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$2.34
52 Week High
$2.29
$12.03

Technical Indicators

Market Signals
Indicator
ZCMD
ACON
Relative Strength Index (RSI) 12.24 56.38
Support Level N/A $3.01
Resistance Level $0.71 $3.52
Average True Range (ATR) 0.25 0.16
MACD -0.16 0.01
Stochastic Oscillator 1.49 80.00

Price Performance

Historical Comparison
ZCMD
ACON

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: